Vimarsana
Biggest News Aggregation in the World

Page 6 - Sheet Information News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sheet Information. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sheet Information Today - Breaking & Trending Today

Tractor Supply Company Reports Record Third Quarter 2021 Financial Results - Vimarsana News

Tractor Supply Company Reports Record Third Quarter 2021 Financial Results

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
Glatfelter : NON-GAAP MEASURES - Form 8-K - Vimarsana News

Glatfelter : NON-GAAP MEASURES - Form 8-K

NON-GAAP MEASURES To supplement our financial information presented in this offering memorandum that are presented in accordance with generally accepted... | October 12, 2021

Wyndham Worldwide Corporation: Results for first half 2016 - Vimarsana News

Wyndham Worldwide Corporation: Results for first half 2016

Second quarter revenues were $1.4 billion – flat compared with the prior year period for Wyndham Hotel Group. In constant currency and excluding acquisitions, revenues increased 1%. Net income for the second quarter of 2016 was $156 million, or $1.39 per diluted share, compared with $159 million, or $1.33 per diluted share, for the second quarter of 2015. Adjusted net income for the second quarter of 2016 was $156 million, or $1.40 per diluted share, compared with $159 million, or $1.32 per diluted share, for the second quarter of 2015. Net income was impacted by higher interest expense an...

Axsome Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update - Vimarsana News

Axsome Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update

Published: May 10, 2021 NEW YORK, May 10, 2021 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today reported financial results for the first quarter ended March 31, 2021. “We continued to make significant strides in the quarter toward becoming a premier biopharmaceutical company focused on delivering potentially life-changing medicines to people living with serious CNS conditions. We successfully filed our NDA for AXS-05 for the treatment of MDD with the F...

Axsome Therapeutics Reports First Quarter 2021 Financial - Vimarsana News

Axsome Therapeutics Reports First Quarter 2021 Financial

AXS-07 for migraine, NDA submission (2Q 2021) AXS-05 for smoking cessation, FDA meeting (3Q 2021) AXS-05 for MDD, commercial launch, if approved (2H 2021) Clinical Trial Readouts: Clinical Trial Initiations: Upcoming Scientific Conferences International Society for Pharmacoeconomics and Outcomes Research (ISPOR) annual meeting, May 17-20, 2021 American Society for Clinical Psychopharmacology (ASCP) annual meeting, June 1-4, 2021 American Headache Society (AHS) annual meeting, June 3-6, 2021 Upcoming Investor Conferences BofA Health Care Conference, May 11, 2021 (to be webcast) RBC Capital Mar...